Drugplain

Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen 27 mg/mL

Ensulizole · LIQUID · SICOS ET CIE

No Recall History
Plain English

Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen is a liquid containing ensulizole at 27 mg/mL, taken topical. Manufactured by SICOS ET CIE.

Key Facts

Brand Name
Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen
Generic Name
Ensulizole
NDC Code (Product)
51150-380
Manufacturer
SICOS ET CIE
Strength
27 mg/mL
Dosage Form
LIQUID
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
06/01/2023

Recall History

No Recall History

Frequently Asked Questions

What is Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen used for?

Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen contains Ensulizole. It is a liquid taken topical. Consult your doctor for specific uses.

Is Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen a controlled substance?

Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen is not classified as a controlled substance by the DEA.

What is the generic name for Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen?

The generic name for Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen is Ensulizole. There are 12 other brand versions of Ensulizole.

What is the NDC code for Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen 27 mg/mL?

The NDC (National Drug Code) for Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreen 27 mg/mL is 51150-380, listed by SICOS ET CIE.